ABPRO Holdings Inc (ABP)

Currency in USD
0.26
-0.02(-7.11%)
Real-time Data·
ABP Scorecard
Full Analysis
Stock generally trades with high price volatility
ABP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.250.27
52 wk Range
0.1513.00
Key Statistics
Prev. Close
0.28
Open
0.26
Day's Range
0.25-0.27
52 wk Range
0.15-13
Volume
4.31M
Average Volume (3m)
18.34M
1-Year Change
-97.47%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ABP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.00
Upside
+669.23%
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets

ABPRO Holdings Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

ABPRO Holdings Inc Company Profile

Abpro Holdings, Inc., a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology. Its platforms include DiversImmune, a discovery platform that generates a diverse collection of proprietary antibodies against clinically validated and novel targets; and MultiMab, an engineering platform that provides the flexibility to combine antibody building blocks in different combinations and orientations to create fit for purpose novel full-length multi-specific antibody constructs. The company’s lead product candidates include ABP-102, a next generation immuno-oncology TetraBi antibody targeting HER2 and CD3 is developed for the treatment of HER2+ solid tumors, including breast and gastric cancers; and ABP-201, a TetraBi antibody format that simultaneously inhibit VEGF and ANG-2 for the treatment of vascular diseases of the eye, including diabetic macular edema and wet age-related macular degeneration. It also develops ABP-110, a TetraBi antibody targeting GPC3 and CD3 for the treatment of hepatocellular carcinoma; and ABP-150, a TetraBi antibody targeting claudin 18.2 and CD3 for the treatment of gastric cancers. The company has strategic partnership with Celltrion Inc. and Abpro Bio International, Inc. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.

Compare ABP to Peers and Sector

Metrics to compare
ABP
Peers
Sector
Relationship
P/E Ratio
0.0x0.0x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.0x2.6x
Price / LTM Sales
0.0x0.0x3.3x
Upside (Analyst Target)
0.0%0.0%42.8%
Fair Value Upside
Unlock0.0%6.5%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 2.00
(+669.23% Upside)

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-0.08 / -0.04
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ABP Income Statement

People Also Watch

34.25
BMNR
+2.85%
0.0600
RAYA
-9.09%
5.355
GVH
-1.02%
1.8831
OST
-12.00%
0.04
GIBO
-20.00%

FAQ

What Stock Exchange Does ABPRO Holdings Trade On?

ABPRO Holdings is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for ABPRO Holdings?

The stock symbol for ABPRO Holdings is "ABP."

What Is the ABPRO Holdings Market Cap?

As of today, ABPRO Holdings market cap is 47.13M.

What Is ABPRO Holdings's Earnings Per Share (TTM)?

The ABPRO Holdings EPS (TTM) is -0.69.

From a Technical Analysis Perspective, Is ABP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has ABPRO Holdings Stock Split?

ABPRO Holdings has split 0 times.

How Many Employees Does ABPRO Holdings Have?

ABPRO Holdings has 11 employees.

What is the current trading status of ABPRO Holdings (ABP)?

As of 06 Aug 2025, ABPRO Holdings (ABP) is trading at a price of 0.26, with a previous close of 0.28. The stock has fluctuated within a day range of 0.25 to 0.27, while its 52-week range spans from 0.15 to 13.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.